Pharmacoeconomics : from theory to practice

著者

    • Arnold, Renée J. G.

書誌事項

Pharmacoeconomics : from theory to practice

edited by Renée J.G. Arnold

（Drug discovery series, 13）

CRC Press, c2010

  • : hardcover

大学図書館所蔵 件 / 全2件

この図書・雑誌をさがす

注記

Includes bibliographical references and index

内容説明・目次

内容説明

The pharmaceutical industry is almost boundless in its ability to supply new drug therapies, but how does one decide which are the best medicines to use within restricted budgets? With particular emphasis on modeling, methodologies, data sources, and application to real-world dilemmas, Pharmacoeconomics: From Theory to Practice provides an introduction to the major concepts and principles of pharmacoeconomics and cost-effectiveness analysis (CEA). As a running theme, the book explores the collaboration among members of the pharmaceutical industry, academia, and government in the development of the human papillomavirus vaccine to demonstrate the full range of ethical and moral issues, as well as overall public health and commercial concerns that are often involved in decisions entailing CEA. Readers will learn about the international use of pharmacoeconomics in drug regulation, drug approval, and pricing, and the book provides examples of pharmacoeconomic models used to support these purposes in government, the pharmaceutical industry, and healthcare settings. In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, drug approval, rationing, patient segmentation, disease management, and pricing model development. Focusing on how to save money, not by restricting access to necessary services, but by using available resources more efficiently and rationally, this volume arms decision makers with the tools they need to make wise choices in an area where the stakes are so high. Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.

目次

Introduction to Pharmacoeconomics, W. F. McGhan Decision Modeling Techniques, M. S. Roberts and K. J. Smith Cost of Illness, R. J. G. Arnold Markov Modeling in Decision Analysis, J. R. Beck Retrospective Database Analysis, R. J. G. Arnold and S. Balu What is Cost-Minimization Analysis?, A. Haycox Cost-Effectiveness Analysis, K. J. Smith and M. S. Roberts Budget Impact Analysis, L. Annemans Cost-Utility Analysis: A Case Study of a Quadrivalent Human Papillomavirus Vaccine, E. J. Dasbach, R. P. Insinga, and E. H. Elbasha Some Problems/Assumptions in Pharmacoeconomic Analysis, S. Birks Patient-Reported Outcome Measures, D. Bryant, G. Guyatt, and R. J. G. Arnold Sensitivity Analysis, M. J. Postma Use of Pharmacoeconomics in Drug Reimbursement in Australia, Canada, and the United Kingdom: What Can We Learn from International Experience?, M. Drummond and C. Sorenson Pharmacoeconomics in Disease Management: Practical Applications and Persistent Challenges, R. Suh and D. Atkins Computer Aided Decision Making from Drug Discovery to Pharmacoeconomics, S. Ekins and R. J. G. Arnold Speculations on the Future Challenges and Value of Pharmacoeconomics, J. J. Caro, D. Getsios, and R. L. Fleurence Index

「Nielsen BookData」 より

関連文献： 1件中  1-1を表示

詳細情報

ページトップへ